logo

BTAI

Bioxcel Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

BTAI fundamentals

Bioxcel Therapeutics (BTAI) released its earnings on Aug 12, 2025: revenue was 120.00K (YoY -89.09%), missed estimates; EPS was -2.45 (YoY -1066.67%), missed estimates.
Revenue / YoY
120.00K
-89.09%
EPS / YoY
-2.45
-1066.67%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

BTAI has released its 2025 Q3 earnings report, with revenue of 98.00K, reflecting a YoY change of -54.21%, and net profit of -30.91M, showing a YoY change of -126.45%. The Sankey diagram below clearly presents BTAI's revenue sources and cost distribution.

Key Indicators

Bioxcel Therapeutics (BTAI) key financial stats and ratios, covering profitability, financial health, and leverage.
Bioxcel Therapeutics (BTAI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bioxcel Therapeutics (BTAI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bioxcel Therapeutics (BTAI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bioxcel Therapeutics (BTAI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bioxcel Therapeutics (BTAI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield